Applications for San Francisco (Batch 12) extended AGAIN through September 30th, 2021!

Learn more about investing in Aluna Medical Diagnostics

Our team will get back to you soon to follow up on your inquiry.
Aluna Medical Diagnostics
Don't let asthma weigh you down.
Founded
2013
Employees*
1-10
Funding to Date*
$2.3M
Website
knox.co
Charvi Shetty
Asthma shouldn't be unpredictable and stressful. We're giving patients and their doctors the tools to stay on top of it. The best part is hearing from kids how Aluna is changing their life.
Asthma is the most common chronic condition among children anf third leading cause of hospitalization among children under the age of 15 years.

Before Aluna, patients had no way of objectively tracking their Asthma to understand triggers, measure lung function, and predict Asthma attachs.

Aluna’s platform empowers patients and clinicians to create personal action plans for their Asthma with FDA-cleared combination of a digital spirometer, a healthtracking platform, and a physician remote monitoring portal. They are currently fulfilling orders from clinicians at UCSF and family practice across the US. By enabling telemedicine Aluna has shown clinicians can intervene quickly when patients scores decrease and prevent severe symptoms.

With 41M patients suffering from Asthma or COPD, and use for COVID lung health recovery monitoring, Aluna is poised to be the solution for respiratory monitoring and care.